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Abstract
Objectives
To assess and compare the self-perceived Health Related Quality of Life (HRQoL) of multi-
morbid patients and the general population using health utilities (HU) and visual analogue
scale (VAS) methods.
Methods
We analyzed data (n = 888) from a national, cross-sectional Swiss study of multimorbid
patients recruited in primary care settings. Self-perceived HRQoL was assessed using the
EQ-5D-3L instrument, composed of 1) a questionnaire on the five dimensions of mobility,
self-care, usual activities, pain/discomfort, and anxiety/depression (EQ-5D dimensions),
and 2) a 0–100 (0 = worst- and 100 = best-imaginable health status) VAS. We described the
EQ-5D dimensions and VAS and computed HU using a standard pan-European value set.
HU and VAS are the two components of the overall HRQoL assessment. We examined the
proportions of multimorbid patients reporting problems (moderate/severe) in each EQ-5D
dimension, corresponding proportions without problems, and mean HU and VAS values
across patient characteristics. To test differences between subgroups, we used chi-square
tests for dichotomous outcomes and T-tests (ANOVA if more than two groups) for continu-
ous outcomes. Finally, we compared observed and predicted HU and VAS values.
Results
All 888 participants answered every EQ-5D item. Mean (SD) HU and VAS values were 0.70
(0.18) and 63.2 (19.2), respectively. HU and VAS were considerably and significantly lower
in multimorbid patients than in the general population and were also lower in multimorbid
patients below 60 years old and in women. Differences between observed and predicted
means (SD) were -0.07 (0.18) for HU and -11.8 (20.3) for VAS.
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Conclusions
Self-perceived HRQoL is considerably and significantly affected by multimorbidity. More
attention should be given to developing interventions that improve the HRQoL of multimor-
bid patients, particularly women and those aged below 60 years old.
Introduction
Multimorbidity, commonly defined as the co-occurrence of two or more chronic conditions
in one individual [1–3], is increasing due to improved living conditions, better medical care,
and an aging population [4, 5]. Multimorbidity is associated with increased rates of mortality
and disability, reduced levels of function, increased polypharmacy, poor health-related quality
of life (HRQoL), and a greater utilization of healthcare resources (costs, number of physician
visits, length of hospital stay) [6]. Indeed, multimorbidity is recognized as a significant health-
care system cost and a major public health issue deserving more research [7]. As multimorbid-
ity becomes more prevalent worldwide, it is becoming a more relevant, clinically important
topic. In Switzerland, multimorbid patients are estimated to make up 20%–30% of the general
population [8].
The cumulative effects of multiple chronic conditions on an individual are complex; spe-
cific combinations of conditions may have greater effects on functional status, quality of life
(QoL), and mortality than others [9, 10]. Several studies have shown that multimorbidity is sig-
nificantly associated with poor HRQoL in adult patients [11–13]. However, little is known
about multimorbid patients’ self-perceived HRQoL in comparison with the general population
and in different multimorbid patient age groups.
We aimed to assess multimorbid patients’ self-perceived QoL and compare the results with
findings from a general population by using two components of the EQ-5D-3L instrument:
health utilities (HU) and visual analogue scale (VAS) scores. This will provide information to
guide future clinical and policy decision-making for the better care of multimorbid patients in
primary care in Switzerland. The EQ-5D-3L is a widely used generic instrument to measure
and evaluate health status; it provides a simple descriptive profile and a single index for health
status that can be used in the clinical and economic evaluation of healthcare, as well as in pop-
ulation health surveys [14].
The hypothesis was that multimorbid patients might suffer from more limitations to the
physical and functional activities that have an impact on their HU and VAS than to the general
population. A further hypothesis was that the QoL of older multimorbid patients would be
worse than that of younger multimorbid patients. Although several studies have assessed the
QoL of multimorbid patients, to the best of our knowledge, none have ever assessed their HU
and VAS using the EQ-5D-3L instrument and compared them to the general population. The
present study aimed to fill this gap.
Materials and methods
Participants and procedures
We analyzed data (n = 888) from a national cross-sectional survey conducted in collaboration
with Switzerland’s five Institutes of Family Medicine, between January and September 2015.
That study was designed to assess multimorbidity in patients in primary care settings. The
detailed study protocol and its initial results have been published elsewhere [15, 16].
Quality of life in multimorbid patients
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Briefly, a convenience sample of 100 general practitioners (GPs) randomly enrolled multi-
morbid participants attending their practices during the study period. Each GP was provided
with a randomization calendar specifying which patients to enroll during each half-day of the
recruitment weeks. Eligible patients were aged 18 years old and over and had at least three
chronic conditions on a list of 75 (“S Tabe 1”) [17]. The GPs informed each eligible patient
about the study and its procedures and asked for their written consent. The study protocol
(Protocol No 314/15) was approved by the Human Research Ethics Committee of the Canton
Vaud.
Measures
The EQ-5D-3L. Self-perceived QoL was assessed using the EQ-5D-3L instrument [14,
18], a widely used, two-part generic instrument for measuring and evaluating HRQoL [14, 19–
21].
- The first part is a questionnaire of EQ-5D items (relating to the five dimensions of mobil-
ity, self-care, usual activities, pain/discomfort, and anxiety/depression) that is frequently used
to measure HU in medical and public health research [20, 21]. Participants report their per-
ceived health status by rating each dimension, using a three-level ordinal scale, as “no prob-
lem” (scored 1), a “moderate problem” (scored 2), or a “severe problem” (scored 3). This
results in a total of 243 (i.e., 35) different possible combinations of health states for mobility,
self-care, usual activities, pain/discomfort, and anxiety/depression. A result of ‘11121‘means
that four EQ-5D dimensions were rated “no problem”, but that pain/discomfort was rated as a
“moderate problem”. The five dimensions can also be combined into a single measure by
using a unified scoring algorithm derived from the time trade-off data from several European
studies [14, 20–22]. HU are self-reported overall measures of HRQoL; they are measured on a
scale between 0 (representing a state of death) and 1 (representing perfect health) [21, 23]. Per-
neger et al. provided reference values for the general population (in French-speaking Switzer-
land) which can be used to assess the utility loss of specific health states.
- The second part of the EQ-5D-3L instrument is a visual analog scale (VAS), presented like
a “thermometer” ranging from 0 to 100, and used to assess self-perceived global levels of
health, where 0 represents the worst imaginable state of health and 100 represents the best
imaginable state [20, 21].
Covariates. Demographic covariates included age, sex (female/male), marital status (sin-
gle, married, divorced, or widow/er), education (compulsory education, upper secondary
level, tertiary level), language (French/German), number of chronic conditions (3–4, 5–6,
or 7), number of prescribed medicines (0–4, 5–6, 7–9, or 10), number of medical visits in
the last month (1–2, 3–4, or 5), hospitalization in the last year (yes/no), and the severity
index (low = low severity of organ dysfunction, or high = high severity of organ dysfunction).
The severity index is derived from the cumulative illness rating scale (CIRS) [24]. The CIRS is
a validated questionnaire grading the scale of impairment in each organ system, from 0–4 in
14 categories. GPs were asked to rate each participating patient across the different categories
of the CIRS. The severity index (SI) [25–27] was obtained by dividing the total score by the
number of categories with morbidities.
Statistical analyses
We performed four main analyses. First, we described the EQ-5D items and the VAS in multi-
morbid patients. Second, we computed the HU for each multimorbid patient using a standard
pan-European value set [14]. For each of the five EQ-5D items, we dichotomized the popula-
tion into multimorbid patients with a problem (moderate/severe) and multimorbid patients
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without a problem, examined the proportions for each health domain, and calculated mean
HU and mean VAS values across patient characteristics (i.e., age, sex, marital status, language,
education, medical visits in the last month, hospitalizations in the last year, number of chronic
conditions, number of medicines prescribed, and severity index derived from the CIRS) [24].
To test differences between subgroups in univariate analyses, we used chi-square tests for
dichotomous outcomes and Welch T-tests (ANOVA if more than two groups) for continuous
outcomes. Third, we examined the frequencies of the most common health states among the
243 possible combinations for each of the EQ-5D domains [14].
Finally, to compare the estimated HU and VAS values in our sample with those of the gen-
eral population, we used the previously published reference values generated from 1,952 ran-
domly selected adults in the French-speaking part of Switzerland [21].
All analyses were conducted using Stata software, version 14 (StataCorp LP, College Station,
TX, USA).
Results
The mean age (SD) of the 888 participants was 72.9 (12.0) years (range 28–98); 51.8% were
women; 49.2% were married; 38.3% were French-speaking; 23.3% had more than seven chronic
conditions; and 83.1% had a low severity index (i.e., low severity of organ dysfunction).
All 888 participants answered all five EQ-5D items, and the most frequently reported
response in the domains of mobility (56%), self-care (88.4%), usual activities (61.2%), and anx-
iety/depression (58.1%) was “no problem”. For pain/discomfort, most participants reported a
moderate problem (66.5%).
The mean (SD) HU value was 0.70 (0.18). The mean (SD) VAS value was 63.2 (19.2), with a
minimum of 0 and a maximum of 100. Mean VAS of each three-point scale for mobility, self-
care, usual activities, pain/discomfort, and anxiety/depression dimensions are presented in
Table 1.
Only 68 of the 243 different possible health states were represented in our sample, with 30
health states selected relatively more often (i.e., with n 5) and 38 selected at “other” frequen-
cies, i.e., all the health states with n < 5 participants (of these, 25 health states were only
selected by one participant each). The most represented health state in our sample was “11121”
(n = 143), i.e. “no problem” with mobility, self-care, usual activities, and anxiety/depression,
and “moderate problems” with pain/discomfort. The best possible health state (i.e., “11111”
and a “no problem” rating for all five EQ-5D items) was reported by 121 participants (13.6%);
their mean HU value was 0.98, and their mean (SD) VAS was 78 (14.2). The health state repre-
sented by “22232” (i.e., a “moderate problem” with four EQ-5D items, but “severe problems”
with pain/discomfort) was selected by seven participants; their health state had the lowest
mean HU value (0.26) and mean VAS (40.0). The most frequently selected EQ-5D health states
and the distributions of their corresponding HU and VAS values are presented in Table 2.
In the overall sample of multimorbid patients, the proportions with a moderate or severe
problem were 76.24% for pain/discomfort, 44% for mobility, 41.9% for anxiety/depression,
38.8% for daily activities, and 11.6% for self-care. Women reported significantly more prob-
lems than men in all dimensions except self-care (p = 0.73). Patients aged> 80 years old
reported more problems with mobility (p< 0.0001); patients aged< 60 years old reported
more problems with daily activities (p = 0.02) and anxiety/depression (p< 0.0001). Patients
hospitalized in the last year, with a high number of chronic conditions, and with a high severity
index reported more problems in all five dimensions.
With regards to means for HU and VAS, significant differences were found according to
sex, i.e., women had lower mean HU and VAS scores than men (p< 0.0001), and
Quality of life in multimorbid patients
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patients < 60 years old had lower mean HU and VAS than older patients (p< 0.0001). The
comparisons between different subgroups of multimorbid patients are presented in Table 3.
The observed mean HU and VAS values in all multimorbid patients were significantly
lower than the values predicted by the general population and, moreover, were also signifi-
cantly lower in multimorbid patients below 60 years old. We also found differences between
observed and predicted values by sex. The difference between the present study’s observed and
predicted mean values of HU and VAS were significant and are presented in Table 4.
Discussion
The present study showed that self-perceived HU and VAS values were significantly lower in
multimorbid patients in primary care than in Switzerland’s general population, i.e., self-per-
ceived values of HU and VAS in our sample were lower than predicted values, with a consider-
ably greater difference in the case of VAS. Moreover, we found that in our sample, self-
perceived HU and VAS values were considerably and significantly lower in multimorbid
patients below 60 years old than in older ones, and in women than in men. Although several
studies have assessed QoL in multimorbid patients, to the best of our knowledge, this study is
the first to provide information about self-perceived HU and VAS values using the EQ-5D-3L
instrument in multimorbid patients with at least three chronic conditions in a primary care
setting.
The present study’s main results were that self-perceived HU and VAS values were signifi-
cantly lower in multimorbid patients than in Switzerland’s general population [21], confirm-
ing our hypothesis. In fact, although we expected to see lower HU and VAS values in
multimorbid patients than in the general population, the differences were surprisingly large,
Table 1. Distributions of the EQ-5D-3L (EQ-5D items and visual analog scale) among multimorbid
patients. N = 888.
EQ-5D N (%) VAS (SD)
Mobility
No problem 497 (56.0) 68.7 (18.0)
Moderate problem 386 (43.5) 56.5 (18.4)
Severe problem 5 (0.6) 34.0 (18.2)
Self-care
No problem 785 (88.4) 65.1 (18.1)
Moderate problem 92 (10.4) 49.6 (21.1)
Severe problem 11 (1.2) 41.8 (22.6)
Usual activities
No problem 543 (61.2) 69.3 (17.1)
Moderate problem 328 (36.9) 54.7 (17.4)
Severe problem 17 (1.9) 31.8 (23.9)
Pain/discomfort
No problem 211 (23.8) 74.1 (16.5)
Moderate problem 591 (66.5) 61.7 (17.4)
Severe problem 86 (9.7) 46.5 (22.1)
Anxiety/depression
No problem 516 (58.1) 68.2 (17.7)
Moderate problem 329 (37.0) 57.8 (18.1)
Severe problem 43 (4.9) 44.2 (22.9)
VAS: visual analog scale
https://doi.org/10.1371/journal.pone.0188499.t001
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especially for the VAS score. This result could be explained by the fact that multimorbidity is
associated with poor QoL [6] and that multiple factors relating to multimorbidity (i.e., disease
burden, treatment burden) can affect daily activities and well-being, including loss of indepen-
dence and autonomy. These factors can have a far greater impact on the QoL of multimorbid
patients than they would on the general population, which faces them less frequently. Mitt-
mann et al. showed that HU were lower in people with one chronic condition [28], and
Manuel et al. showed that HU varied from one condition to another [23]. These studies sug-
gested that multimorbidity may have a negative impact on perceived health outcomes and thus
Table 2. Most frequently reported EQ-5D health states and distributions of corresponding mean HU
and mean VAS values among a sample of multimorbid patients. N = 888.
Health state* N (%) Health utility Mean VAS (SD)
11121 143 (16.1) 0.78 70.7 (16.4)
11111 121 (13.6) 0.98 78.0 (14.2)
21121 69 (7.8) 0.72 64.6 (15.5)
11122 66 (7.4) 0.70 66.1 (15.8)
21222 66 (7.4) 0.62 55.6 (13.4)
21221 48 (5.4) 0.70 58.5 (14.9)
21122 39 (4.4) 0.65 59.3 (15.6)
11222 36 (4.0) 0.68 58.4 (17.5)
11112 35 (3.9) 0.79 71.7 (17.3)
11221 31 (3.5) 0.76 63.2 (14.0)
22222 21 (2.4) 0.52 47.4 (13.7)
21111 19 (2.1) 0.81 68.7 (19.0)
21232 15 (1.7) 0.36 40.7 (12.7)
11123 12 (1.3) 0.47 55.0 (19.3)
22221 11(1.2) 0.60 58.2 (8.7)
21131 10 (1.1) 0.46 59.5 (19.8)
21231 10 (1.1) 0.44 56.0 (22.8)
21223 8 (0.9) 0.39 51.9 (16.5)
22232 7 (0.8) 0.26 40.0 (23.3)
21211 7 (0.8) 0.78 72.1 (14.7)
11232 6 (0.7) 0.42 49.2 (11.1)
11212 6 (0.7) 0.76 64.2 (17.4)
11131 6 (0.7) 0.52 67.5 (17.2)
11211 6 (0.7) 0.84 60.8 (17.0)
12221 6 (0.7) 0.66 62.7 (16.3)
21112 5 (0.6) 0.73 67.0 (12.0)
22121 5 (0.6) 0.62 74.0 (11.4)
12222 5 (0.6) 0.58 54.0 (8.9)
22231 5 (0.6) 0.34 57.0 (17.9)
21233 5 (0.6) 0.33 43.0 (31.1)
Other‡ 59 (6.6) — —
*The health-scale column’s numbers represent scores for mobility, self-care, usual activities, pain/
discomfort, and anxiety/depression (1 = no problem, 2 = moderate problem, 3 = severe problem). For
example, “11121” means that all the EQ-5D items were rated “no problem”, except for pain/discomfort,
which was rated “moderate problem”.
‡ Other regroups includes all the less frequently reported health states (n < 5)
VAS: visual analog scale
https://doi.org/10.1371/journal.pone.0188499.t002
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Table 3. Univariate subgroup comparisons in the sample of multimorbid patients. N = 888.
N (%) No problem
N (%)
Problem with
mobility N
(%)
Problem with
self-care N
(%)
Problem with
daily
activities
N (%)
Problem with
pain or
discomfort
N (%)
Problem with
anxiety or
depression
N (%)
Mean health
utility (SD)
Mean
VAS (SD)
Total 888
(100)
121 (13.6) 391 (44.0) 103 (11.6) 345 (38.9) 677 (76.2) 372 (41.9) 0.70 (0.18) 63.2
(19.3)
Sex p < 0.0001 p = 0.0125 p = 0.7302 p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001
Men 428
(48.2)
86 (20.1) 170 (39.7) 48 (11.2) 133 (31.1) 301 (70.3) 134 (31.3) 0.73 (0.18) 66.0
(18.8)
Women 460
(51.8)
35 (7.6) 221 (48.0) 55 (12.0) 212 (46.1) 376 (81.7) 238 (51.7) 0.67 (0.17) 60.5
(19.3)
Age group p = 0.0814 p = 0.0002 p = 0.3479 p = 0.0194 p = 0.7456 p < 0.0001 p < 0.0001 p < 0.0001
< 60 128
(14.4)
13 (10.2) 47 (36.7) 17 (13.3) 63 (49.2) 100 (78.1) 93 (72.7) 0.63 (0.21) 55.7
(22.0)
60–79 482
(54.3)
77 (16.0) 194 (40.2) 49 (10.2) 172 (35.7) 369 (76.6) 186 (38.6) 0.71 (0.18) 65.4
(18.7)
 80 278
(31.3)
31 (11.2) 150 (54.0) 37 (13.3) 110 (39.6) 208 (74.8) 93 (33.5) 0.71 (0.15) 62.9
(17.9)
Marital status p = 0.0214 p = 0.0001 p = 0.3405 p = 0.0038 p = 0.4708 p = 0.0009 p = 0.0021 p = 0.0001
Single 85
(9.6)
8 (9.4) 31 (36.5) 9 (10.6) 30 (35.3) 65 (76.5) 47 (55.3) 0.69 (0.17) 62.6
(20.6)
Married 437
(49.2)
71 (16.2) 172 (39.4) 43 (9.8) 149 (34.1) 328 (75.1) 159 (36.4) 0.72 (0.17) 65.6
(18.7)
Divorced 150
(16.9)
24 (16.0) 65 (43.3) 21 (14.0) 75 (50.0) 111 (74.0) 76 (50.7) 0.66 (0.21) 57.4
(19.5)
Widow/er 216
(24.3)
18 (8.3) 123 (56.9) 30 (13.9) 91 (42.1) 173 (80.1) 90 (41.7) 0.69 (0.16) 62.6
(18.9)
Education* p = 0.5804 p = 0.5926 p = 0.8371 p = 0.5093 p = 0.4651 p = 0.1999 p = 0.3000 p = 0.3562
Compulsory
education
195
(22.0)
23 (11.8) 92 (47.2) 25 (12.8) 70 (35.9) 155 (79.5) 90 (46.2) 0.68 (0.18) 61.9
(19.0)
Upper secondary
level
337
(38.0)
45 (13.4) 145 (43.0) 38 (11.3) 138 (40.9) 255 (75.7) 145 (43.0) 0.70 (0.17) 62.8
(18.7)
Tertiary level 355
(40.0)
53 (14.9) 153 (43.1) 40 (11.3) 137 (38.6) 266 (74.9) 137 (38.6) 0.71 (0.18) 64.3
(19.9)
Medical visits in the last
month
p = 0.3543 p = 0.1171 p = 0.0465 p = 0.0215 p = 0.1960 p = 0.6719 p = 0.7038 p = 0.5885
1–2 visits 692
(77.9)
100 (14.5) 292 (42.2) 77 (11.1) 255 (36.8) 525 (75.9) 292 (42.2) 0.70 (0.18) 63.5
(19.6)
3–4 visits 141
(15.9)
14 (9.9) 71 (50.4) 14 (9.9) 60 (42.6) 114 (80.9) 55 (39.0) 0.69 (0.17) 62.9
(19.3)
 5 visits 55
(6.2)
7 (12.7) 28 (50.9) 12 (21.8) 30 (54.5) 38 (69.1) 25 (45.5) 0.69 (0.19) 60.7
(14.4)
Hospitalization** p = 0.3375 p = 0.0054 p = 0.0037 p = 0.0031 p = 0.4352 p = 0.6029 p = 0.0095 p = 0.0083
No 593
(67.0)
85 (14.3) 242 (40.8) 56 (9.4) 211 (35.6) 449 (75.7) 245 (41.3) 0.71 (0.17) 64.4
(18.9)
Yes 292
(33.0)
35 (12.0) 148 (50.7) 47 (16.1) 134 (45.9) 228 (78.1) 126 (43.2) 0.68 (0.19) 60.7
(19.7)
Number of CC p = 0.0003 p < 0.0001 p < 0.0001 p = 0.0002 p = 0.0022 p = 0.8274 p < 0.0001 p = 0.0701
3–4 343
(38.6)
63 (18.4) 111 (32.4) 26 (7.6) 110 (32.1) 245 (71.4) 140 (40.8) 0.73 (0.17) 64.7
(18.5)
5–6 338
(38.1)
45 (13.3) 162 (47.9) 35 (10.4) 132 (39.1) 257 (76.0) 142 (42.0) 0.70 (0.17) 63.1
(19.8)
7 207
(23.3)
13 (6.3) 118 (57.0) 42 (20.3) 103 (49.8) 175 (84.5) 90 (43.5) 0.65 (0.18) 60.8
(19.3)
(Continued )
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lead to a lower HRQoL resulting in lower HU and VAS. Indeed, multimorbid patients’ QoL
may be affected more than that of people in the general population with just one chronic con-
dition or without any. In other words, in many patients, multiple chronic diseases can interact
with each other, compounding their effects rather than just existing as distinct disorders.
Another important result was that self-perceived HU and VAS values were considerably
lower in multimorbid patients below 60 years old than older multimorbid patients; this trend
was contrary to that observed in the general population, where HU and VAS become lower as
participants get older [21]. Although the measure used was different, Manuel et al. showed
that age had an independent effect on HU [23], such that as age increased, QoL became pro-
portionately more affected. In our sample of multimorbid patients, self-perceived HU and
VAS seemed to improve with age. This could be explained by the fact that as patients with
coexisting multiple chronic conditions get older, they appear to become more accustomed to
their diseases and to have adapted to them. Perhaps they simply accept them because they feel
it is normal to have multiple chronic conditions as one ages and, therefore, they self-reported a
better QoL. Another explanation could be that multimorbid people below 60 years old have
specific types of chronic conditions, not necessarily just those acquired with age and, therefore,
they have difficulty accepting their diseases. A last explanation could be that people with
depression are more likely to perceive a worse QoL [29, 30]. Younger people with chronic con-
ditions are indeed more likely to be depressed than older people [31], and this could explain
why our study’s under-60 group mostly reported a worse QoL than the older participants.
Table 3. (Continued)
N (%) No problem
N (%)
Problem with
mobility N
(%)
Problem with
self-care N
(%)
Problem with
daily
activities
N (%)
Problem with
pain or
discomfort
N (%)
Problem with
anxiety or
depression
N (%)
Mean health
utility (SD)
Mean
VAS (SD)
Number of
medicines
p < 0.0001 p < 0.0001 p = 0.0015 p < 0.0001 p < 0.0001 p = 0.1096 p < 0.0001 p < 0.0001
0–4 156
(17.6)
31 (19.9) 46 (29.5) 10 (6.4) 44 (28.2) 104 (66.7) 60 (38.5) 0.75 (0.16) 68.9
(17.9)
5–6 212
(23.9)
39 (18.4) 82 (38.7) 17 (8.0) 67 (31.6) 148 (69.8) 82 (38.7) 0.74 (0.16) 66.6
(19.2)
7–9 276
(31.1)
40 (14.5) 119 (43.1) 33 (12.0) 110 (39.9) 213 (77.2) 112 (40.6) 0.70 (0.18) 62.2
(17.9)
10–21 244
(27.5)
11 (4.5) 144 (59.0) 43 (17.6) 124 (50.8) 212 (86.9) 118 (48.4) 0.63 (0.18) 57.6
(20.0)
Severity index p = 0.7071 p < 0.0001 p = 0.0648 p = 0.0068 p = 0.9399 p = 0.1935 p = 0.0060 p = 0.0005
Low 738
(83.1)
102 (13.8) 302 (40.9) 79 (10.7) 272 (36.9) 563 (76.3) 302 (40.9) 0.71 (0.17) 64.3
(18.9)
High 150
(16.9)
19 (12.7) 89 (59.3) 24 (16.0) 73 (48.7) 114 (76.0) 70 (46.7) 0.66 (0.20) 58.0
(20.1)
Language p = 0.2028 p = 0.0016 p = 0.1652 p = 0.8768 p = 0.1540 p < 0.0001 p = 0.1592 p = 0.1218
German 548
(61.7)
81 (14.8) 264 (48.2) 70 (12.8) 214 (39.1) 409 (74.6) 201 (36.7) 0.71 (0.18) 64.0
(19.5)
French 340
(38.3)
40 (11.8) 127 (37.4) 33 (9.7) 131 (38.5) 268 (78.8) 171 (50.3) 0.69 (0.17) 61.9
(18.9)
*1 missing
** 3 missing
VAS: visual analog scale
CC: chronic conditions
https://doi.org/10.1371/journal.pone.0188499.t003
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With regards to the EQ-5D’s five different dimensions, the present study’s multimorbid
patients reported “no problem” more frequently than both “moderate problem” and “severe
problem” for mobility, self-care, usual activities, and anxiety/depression. However, they fre-
quently reported a “moderate problem” with pain/discomfort. This result is concordant with
a study of older adults in Spain by Leo´n-Salas et al. [32], and with the results obtained in the
general Swiss population (although not for pain/discomfort) [21], suggesting that the trend
remains the same despite the different populations. This result suggests that when we look at
the five dimensions separately, our sample’s multimorbid patients felt little impact on their
mobility, their ability to take care of themselves and carry out usual activities and their state
of anxiety/depression, whereas they were more affected by pain/discomfort. This could be
because multimorbid patients reported pain/discomfort more readily. As they perceived it,
pain/discomfort was the domain which put the greatest limitations on their lives; it was the
most important and least bearable for them. This result agrees with the study by Pinto-Meza
et al. which showed that chronic pain played a major role in the loss of HRQoL [33]. In pri-
mary care, therefore, we should pay more attention to the QoL of multimorbid patients who
are suffering from pain. On the other hand, most multimorbid patients in the present study
did not report severe problems in the domains of mobility, self-care, usual activities, and anxi-
ety/depression, which suggested that they were not necessarily the patients most affected by
their chronic conditions. Moreover, the majority of our study population had a low severity
index rating, suggesting that they were not as sick and impaired as we might have imagined.
This could be explained by the fact that the study probably did not include many of the most
severely impaired patients: enrollment in the study occurred at GPs’ practices and concerned
all patients with at least three of a list of 75 chronic conditions. Indeed, our goal was not to
only have the most impaired patients but to include all kinds of multimorbid patients with at
least three chronic conditions. Many of the chronic conditions and risk factors observed were
Table 4. Observed and predicted mean health utility and VAS, and the differences between them in 888 multimorbid patients.
EQ-5D health utility Visual analogue scale
Observed (SD) Predicted Difference observed–predicted
(SD)
Observed (SD) Predicted Difference observed–predicted
(SD)
Total 0.70 (0.18) 0.77 -0.07*** (0.18) 63.19 (19.25) 74.98 -11.8*** (20.3)
Sex
Women 0.67 (0.17) 0.77 -0.10*** (0.18) 60.55 (19.33) 74.85 -14.3***(20.6)
Men 0.73 (0.17) 0.76 -0.03** (0.18) 66.03 (18.78) 75.11 -9.1*** (19.7)
Age group
< 60 0.63 (0.21) 0.82 -0.19*** (0.22) 55.67 (22.01) 82.93 -27.3*** (22.2)
60–79 0.71 (0.17) 0.77 -0.06*** (0.18) 66.30 (18.73) 76.39 -11.0*** (18.9)
 80 0.71 (0.15) 0.73 0.02* (0.15) 62.91 (17.92) 68.87 -5.9*** (18.2)
EQ-5D health utility Visual analogue scale
Women Men Women Men
Age group Observed (SD) Predicted Observed (SD) Predicted Observed (SD) Predicted Observed (SD) Predicted
< 60 0.62 (0.2) 0.82 0.64 (0.24) 0.82 55 (22.21) 83.2 56.8 (21.8) 82.5
60–79 0.67 (0.17) 0.77 0.74 (0.17) 0.88 62.6 (18.48) 76.3 67.6 (18.6) 76.4
 80 0.68 (0.15) 0.73 0.75 (0.14) 0.88 60.6 (18.42) 68.6 66.0 (16.8) 69.2
*** p  0.0001
** p 0.001
* p 0.01
https://doi.org/10.1371/journal.pone.0188499.t004
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silent and had a low impact on their daily activities, autonomy, and independence. This result
could suggest that most multimorbid patients who are able to get to their GPs’ practices are
less affected by issues of mobility, self-care, being able to carry out usual activities, and anxi-
ety/depression. They thus reported fewer of these as QoL problems. Had patients who could
not attend their GPs’ practices been enrolled in the study (i.e. patients receiving regular
home visits, living in nursing homes, or hospitalized), its results could have been signifi-
cantly different.
Women reported significantly more problems than men in every health dimension but self-
care. They also reported lower mean HU and VAS values than men, suggesting that multimor-
bid women’s overall HRQoL is more affected by their chronic conditions than multimorbid
men’s. The study sample’s trend for HU by sex was the same as that for the general population
[21]. This result is also in accordance with the studies by Wai Yang Loo et al. [34] and Scirè
et al. [35], although their populations and HRQoL measurements were different. These two
studies showed that female participants perceived a greater degree of physical impairment and
poorer overall HRQoL than male participants. Their results can be explained by the fact that it
has been consistently shown that women have poorer health than men [36–38], thus poorer
health inevitably leads to poorer QoL. The fact that the women in the present study reported
fewer problems in the dimension of self-care could be because they are better than men at tak-
ing care of themselves. Alternatively, they may not have reported problems of self-care in
order to avoid having to ask for help in this domain.
The EQ-5D-3L instrument’s best possible, problem-free health status (i.e., “11111”) was
reported by 13.6% in our sample of multimorbid patients. This could be because multimorbid
patients suffering from chronic conditions that are not very symptomatic, and thus have little
impact on their QoL, feel that they have no problems. Indeed, the present study’s criteria for
patient inclusion defined multimorbidity as having at least three chronic conditions, but there
were no criteria as to the severity or degree of impairment caused by each condition. However,
we can only speculate on this, as the present study was unable to associate the different health
states to clusters of patients with chronic conditions.
Strengths and limitations
This national primary care study analyzed data from a representative sample of multimorbid
patients with at least three chronic conditions, enrolled in GPs’ practices across Switzerland.
Although several studies have previously assessed the QoL of multimorbid patients, to the best
of our knowledge, this is the first to have assessed their self-perceived HU and VAS values
using the EQ-5D-3L instrument in a primary care setting. Results showed considerable differ-
ences between the study population and the country’s general population.
However, this study has some limitations. First, the sample might not be representative of
all multimorbid patients. GPs only recruited patients who came to their practices and who had
at least three chronic conditions from a list of 75 provided to them. Therefore, the most
impaired multimorbid patients, those with the biggest mobility problems (i.e., those cared for
through home visits, in nursing homes, or hospitalized) were not included. These results
should thus be interpreted with caution, bearing in mind the multimorbid patients who cannot
attend GPs’ practices or who have rare chronic conditions.
Second, this study was unable to carry out any assessment of self-perceived HU by cluster
of multimorbid patients with the same three (or more) chronic conditions, or by each condi-
tion’s degree of severity. Indeed, we were unable to define a unique multimorbid profile due to
the high number of combinations of chronic conditions included in the study. However, the
study did allow us to present an overall idea of multimorbid patients’ self-perceived HU.
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Third, the general population sample against which we compared our data was from the
French-speaking part of Switzerland and thus may not be entirely representative of that mainly
German-speaking country.
Conclusions
By using the EQ-5D-3L instrument’s questionnaire about health utilities and its visual ana-
logue scale, in a primary care setting, our findings suggested that quality of life was consider-
ably and significantly lower in multimorbid patients than in the general population. We
believe that measuring self-reported quality of life is an important aid to understanding the
impact of requests for care and, very probably the intensity of care provided to them and thus
healthcare costs. Moreover, our results suggest that quality of life seemed to be significantly
lower in a subgroup of patients below 60 years old and in women. For GPs’ daily practice, this
may imply that multimorbid patients’ overall quality of life should be more carefully assessed,
particularly in those two groups. Similarly, more attention should be given to the development
of interventions that improve the quality of life of multimorbid patients, particularly when
multimorbidity begins to affect them below 60 years old.
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